Free Consultation

Mass Torts

Weight Loss Lawsuit | Stomach Paralysis

Ozempic, Wegovy, Mounjaro, Rybelsus, and Saxenda are drugs first prescribed to treat diabetes and then marketed as weight loss drugs. Hollywood and TikTok celebrities have turned them into sensations. Suddenly, these drugs are everywhere, dominating the weight loss market. However, these miracle weight loss drugs are far from perfect. Novo Nordisk, the maker of Ozempic, and Eli Lilly, the maker of Mounjaro, are now being sued by a Louisiana woman for failing to warn patients of an extreme side effect: stomach paralysis.

Click for Free Case Evaluation

Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


 If you suffered from stomach paralysis or other gastrointestinal injuries after taking these drugs and are seeking answers about your legal options, you are in the right place. Here, Ethen Ostroff Law breaks down the connection between these weight loss/diabetes drugs and stomach paralysis, delves into the legal aspects, and explains how we can assist you in seeking compensation and justice through a weight loss lawsuit.

What are Ozempic, Wegovy, Mounjaro, Rybelsus, and Saxenda for?

Ozempic, Wegovy, Mounjaro, Rybelsus, and Saxenda are Type 2 diabetes medications that all belong to the same class called the glucagon-like peptide-1 (GLP-1) agonists. GLP-1 is a hormone that our small intestine produces. A GLP-1 agonist mimics this hormone.

Our sugar levels begin to rise after we eat. These drugs stimulate our bodies to produce more insulin. The extra insulin produced helps lower our blood sugar levels. In short, GLP-1 agonists work by stimulating insulin release, blocking sugar production in our liver, and making us feel full. The satiety effect of GLP1-agonists reduces food intake, appetite, and hunger. These combined effects frequently result in weight loss.

Doctors prescribe GLP-1 agonists for Type 2 diabetes and obesity. But GLP-1 agonists cannot treat Type 2 diabetes or obesity alone. Other treatment options are needed for both conditions, such as lifestyle and dietary changes. 

What GLP-1 agonists are available in the United States?

The following are GLP-1 agonists currently available on the U.S. market:
  • Novo Nordisk’s Ozempic 
  • Novo Nordisk’s Rybelsus  
  • Novo Nordisk’s Wegovy 
  • Eli Lilly’s Mounjaro  
  • Novo Nordisk’s Saxenda  
  • Eli Lilly’s Trulicity 
  • Amylin Pharmaceuticals’ Byetta 
  • Amylin Pharmaceuticals’ Bydureon 
  • Novo Nordisk’s Victoza 
  • Sanofi-Aventis’ Adlyxin 
Get Free Consultation

What are the differences between GLP-1 agonist drugs?

GLP-1 agonists are medications commonly used for managing diabetes and weight loss.

Let us take a closer look at the distinct features of various options:
  • Ozempic (semaglutide) is a once-a-week injection for adults with Type 2 diabetes. It can be administered at any time of day, on the same day each week, with or without food. Ozempic comes in a multi-dose pre-filled pen. Healthcare providers may recommend Ozempic to patients with Type 2 diabetes and heart disease because it lowers the risk of heart attack and stroke. There is also some evidence suggesting potential kidney benefits. Ozempic is not approved for weight loss. But patients taking Ozempic may notice weight loss as a side effect.
  • Rybelsus is an oral version of semaglutide taken once daily to treat Type 2 diabetes. It is currently the only non-injected medication in the GLP-1 agonist class. Rybelsus is not approved for the same heart-related benefits.
  • Wegovy is a once-a-week semaglutide injection approved only for weight loss in certain adults and adolescents ages 12 and older. It is not used to treat diabetes. Wegovy can be injected at any time of the day. For the best results, Wegovy should be combined with a healthy diet and exercise.
  • Trulicity (dulaglutide) is a once-a-day Type 2 diabetes injection for adults and children aged 10 and above. It comes as a single-use, pre-filled pen. It can be injected on the same day each week at any time of day, with or without food. Like Ozempic, Trulicity can lower the risk of heart attack and stroke in adults who have heart disease. It may also have some kidney-related benefits. Though Trulicity is not approved for weight loss, some people who use it lose weight as a side effect.
  • Victoza (liraglutide) is a once-daily injection for Type 2 diabetes approved for use in people ages 10 and older. It is injected more frequently at any time of day, without regard to food. Victoza can lower the risk of heart attack and stroke in patients with heart disease and help prevent kidney problems from worsening. Victoza is not approved for weight loss, but some people who take it lose weight.
  • Saxenda is a weight loss-approved version of liraglutide. It works best when combined with a healthy diet and exercise.
  • Byetta (exenatide) was the first FDA-approved GLP-1 agonist used to treat Type 2 diabetes in adults. Patients need to inject it more often compared to other options — twice daily within an hour before morning and evening meals. Healthcare providers may recommend Byetta to patients experiencing blood sugar spikes after meals and wanting to lose weight as a side effect. However, Byetta does not offer the same heart-related benefits as other options.
  • Bydureon BCise (exenatide) is a longer-acting version of Byetta that is injected once a week. It is approved to lower blood sugar levels in people ages 10 and older with Type 2 diabetes. Bydureon BCise does not have the same heart-related and weight loss benefits seen with other GLP-1 agonists.
  • Mounjaro (tirzepatide) is part of a brand-new class called GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonists. It works by mimicking two gut hormones: GLP-1 and GIP. For now, Mounjaro is only approved to treat Type 2 diabetes. But it is currently being studied for weight loss benefits. The Food and Drug Administration (FDA) has granted Mounjaro a Fast Track designation.
  • Adlyxin (lixisenatide) is a once-daily incretin mimetic injection for Type 2 diabetes. It is an add-on medication to diet and exercise to improve blood sugar control in people with type 2 diabetes. As of 2023, the drug is no longer available in the United States. 

What are the differences between GLP-1 agonist drugs?

GLP-1 agonist drugs not only improve blood sugar control but can also lead to weight loss. Ozempic, Wegovy, Mounjaro, Rybelsus, and Saxenda are the most popular GLP-1s used to lose weight. However, only Wegovy and Saxenda are approved by the FDA for weight loss. These GLP-1 agonists have well-known side effects, whether used as medication for diabetes or weight loss. Here, we list the mild and serious side effects of these popular weight loss/diabetes drugs.

Wegovy

Some of the mild side effects that Wegovy may have been:
  • Bloating and belly pain 
  • Burping 
  • Constipation 
  • Diarrhea 
  • Dizziness 
  • Gas 
  • Fatigue 
  • Headaches 
  • Heartburn 
  • Indigestion 
  • Nausea 
  • Stomach flu 
  • Vomiting 
  • Allergic reaction 
  • Increased heart rate 
  • Gallbladder problems 
  • Low blood sugar 
  • Pancreatitis 
  • Risk of thyroid cancer 

Ozempic

Some common mild side effects of Ozempic are:
  • Burping 
  • Diarrhea 
  • Dizziness 
  • Headache 
  • Heartburn 
  • Loss of appetite 
  • Low blood sugar if you have type 2 diabetes 
  • Nausea 
  • Stomach flu-like symptoms 
  • Tiredness 
  • Upset stomach 
  • Vomiting 
  • Fluttering in your chest 
  • Light-headed feeling 
  • Pounding heartbeat 
  • Shortness of breath 
  • Swelling in your neck, lump in your neck, or trouble swallowing 
  • Unusual mood changes 
  • Vision changes 

Saxenda

Common side effects of Saxenda are:
  • Abdominal pain or upset stomach 
  • Anxiety 
  • Belching 
  • Bloating 
  • Constipation 
  • Decreased appetite 
  • Diarrhea 
  • Dizziness 
  • Dry mouth 
  • Fatigue 
  • Gas 
  • Headache 
  • Indigestion 
  • Insomnia 
  • Lack of energy 
  • Low blood sugar 
  • Nausea 
  • Redness at the injection site 
  • Vomiting 
  • Weakness 
  • Blurred vision 
  • Confusion 
  • Eye pain 
  • Fast or uneven heartbeats 
  • Fluttering in your chest 
  • High fever 
  • Pounding heartbeat 
  • Seeing halos 
  • Severe nervous system reaction with stiff muscles 
  • Shortness of breath 
  • Slurred speech 
  • Sudden dizziness 
  • Sweating 
  • Tremors 
  • Tunnel vision 

Mounjaro

Common mild side effects of Mounjaro include:
  • Abdominal pain 
  • Abdominal swelling 
  • Acid reflux 
  • Belching 
  • Constipation 
  • Diarrhea 
  • Flatulence 
  • Indigestion 
  • Loss of appetite  
  • Mild allergic reaction (skin rash, itchiness, flashing) 
  • Mild injection site reaction (pain) 
  • Nausea 
  • Vomiting 
  • Gallbladder problems 
  • Pancreatitis 
  • Risk of thyroid cancer 
  • Severe allergic reaction 
  • Severe digestive problems, which may lead to acute kidney injury 

Rybelsus

Common side effects include:
  • Abdominal pain 
  • Bloating and gas 
  • Burping 
  • Constipation 
  • Decreased appetite 
  • Diarrhea 
  • Gastroesophageal reflux disease (GERD) 
  • Heartburn 
  • Nausea 
  • Upset stomach 
  • Vomiting 
  • Weight loss  
  • Allergic reaction 
  • Hypoglycemia (low blood sugar) 
  • Kidney problems, such as kidney failure 
  • Pancreas problems 
  • Risk of thyroid cancer
Get Free Consultation

Stomach Paralysis: An Unfortunate Side Effect

Despite their potential benefits, Ozempic and Mounjaro have been associated with certain gastrointestinal complications, including stomach paralysis, also known as gastroparesis. A Louisiana woman filed an lawsuit against Novo Nordisk and Eli Lilly, respective manufacturers of Ozempic and Mounjaro, for failing to warn patients about the risk of stomach paralysis.

Jaclyn Bjorklund claims she has suffered severe illness and injuries—including vomiting, abdominal pain, gastrointestinal burning, and numerous hospital visits—from using Ozempic and Mounjaro for a year and a half. Bjorklund alleges both drugmakers were aware of the link between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, and that the warnings provided to patients were inaccurate.

Bjorklund claims the medications have caused her to develop gastroparesis, although she has not yet been officially diagnosed with the illness. Gastroparesis is a disorder that slows or stops the movement of food from the stomach to the small intestine. Bjorklund is seeking financial compensation from both companies. 

Weight Loss/Diabetes Drug Lawsuit

If you developed stomach paralysis or other severe gastrointestinal issues after taking Ozempic, Mounjaro, or other GLP-1 agonist drugs, you may be eligible to file a weight loss lawsuit. To win your case, you must establish liability, which means the drug manufacturer, healthcare provider, or other party failed to warn about potential risks or acted negligently in some way.

When pursuing a legal claim for stomach paralysis or other gastrointestinal issues caused by Ozempic, Mounjaro, or other GLP-1 agonist drugs, you may be entitled to the following types of compensation:
  • Medical expenses: Reimbursement for past and future medical bills related to the condition caused by Ozempic, Mounjaro, or other GLP-1 agonist drugs, such as hospitalization, medications, doctor visits, and therapies.
  • Pain and suffering: Compensation for physical and emotional distress caused by the illness and its impact on your daily life
  • Lost wages: Compensation for lost wages and reduced earning capacity if you have been unable to work due to stomach paralysis
  • Wrongful death: Surviving family members may seek compensation through a wrongful death claim in the tragic event of a loved one’s death due to complications from Ozempic, Mounjaro, or other GLP-1 agonist drugs. 

What are the possible claims in a weight loss drug lawsuit?

In weight loss lawsuits concerning stomach paralysis or other serious side effects allegedly caused by Ozempic, Mounjaro, or other weight loss or diabetes drugs, weight loss claims typically revolve around several key points. If you are pursuing legal action, consult with an attorney who specializes in pharmaceutical litigation, like those at Ethen Ostroff Law, to understand the unique aspects of your situation.

The following are some common weight loss drug claims that might be raised against the pharmaceutical companies:
  • Failure to warn: The drugmakers failed to adequately warn about the potential risks and side effects, like stomach paralysis, associated with their drugs.
  • Negligence: The pharmaceutical companies negligently designed, manufactured, marketed, and distributed the drugs. They failed to ensure the drugs were safe for their intended use.
  • Defective product: The drugs were inherently flawed or dangerous, making them unsafe when used as directed.
  • Breach of warranty: The drugmakers breached express or implied warranties by marketing the drugs as safe and effective for weight loss and diabetes management without disclosing the potential risk of stomach paralysis and other serious side effects.
  • Strict liability: The drugs are inherently dangerous, and the pharmaceutical companies should be held liable regardless of whether they were negligent or knew about the specific risks. This claim focuses on the inherent danger of the product itself.
  • False misrepresentation: The pharmaceutical companies intentionally misrepresented or concealed information about the risks associated with the weight loss/diabetes drugs, leading patients to believe the drugs were safer than they are.
  • Lack of adequate rest: The pharmaceutical companies did not conduct adequate testing to identify potential risks before bringing these drugs to market, and this lack of testing contributed to the development of stomach paralysis.
  • Failure to withdraw: If it can be proven that these drugmakers were aware of the risk of stomach paralysis but failed to remove weight loss/diabetes drugs from the market promptly, plaintiffs might claim that the companies were negligent in protecting patients’ safety. 

How Ethen Ostroff Law Can Help in Your Weight Loss Lawsuit

Proving liability often requires thorough investigation and legal expertise. But navigating the complexities of pharmaceutical litigation can be overwhelming, particularly when dealing with medical-related problems. The weight loss/diabetes drug attorneys at Ethen Ostroff Law have a proven track record of handling cases involving dangerous drugs and medical devices. We can guide you through the legal process.

At Ethen Ostroff Law, we are committed to getting the best possible outcome for our clients. We do this by:

  • Conducting in-depth case evaluations to assess the strength of your claim. 
  • Working with medical experts to understand the link between your symptoms and the medication. 
  • Providing solid evidence to support your case. 
  • Negotiating with pharmaceutical companies and their legal teams. 
  • Taking your case to court if a fair weight loss drug settlement cannot be reached. 

  

Do not worry about the expense of bringing a weight loss drug lawsuit. Ethen Ostroff Law and its partner firms work on a contingency fee basis. In other words, you do not pay us unless we get you compensation. Do not fret about the upfront legal fees. Just focus on your recovery and case.

What are you waiting for? Contact Ethen Ostroff Law now at 610-510-8883 ( by calling this number, you consent to receive SMS updates from Ethen Ostroff Law) or Submit Form to get free consultation.

Weight Loss Lawyer

If you want a lawyer who cares about you and the outcome of your weight loss lawsuit, choose Ethen Ostroff. He and his professional connections ensure you get every dollar possible for what you went through.

Success

We received your information. We’ll be in touch soon.

Ok
While in law school, he distinguished himself as Executive Editor of JURIS Magazine, received the prestigious CALI Excellence for the Future Award, and completed five hands-on internships that laid a strong foundation for his legal career.


Nicholas began his post-graduate career clerking for the Honorable Linda Rovder Fleming in the Cambria County Court of Common Pleas. From there, he quickly found his calling in workers’ compensation, personal injury, and Social Security disability law—areas where he could directly impact people’s lives in moments of crisis. He’s helped clients navigate complex legal claims, including securing a settlement exceeding $300,000.

Nicholas brings clear communication, genuine empathy, and an unrelenting drive to achieve the best outcomes for his clients. Whether he’s navigating a complex workers’ comp claim or pushing for a major settlement, he brings focus, dedication, and deep legal knowledge to every case.

He’s also a proud member of Pennsylvania Advocates for Justice and remains active in various professional legal organizations. Nicholas is licensed to practice law in Pennsylvania.

When he’s not fighting for the injured, Nicholas is enjoying time with his family, kicking a soccer ball around, hitting the golf course, or cheering on Pittsburgh’s local teams.

Joe Ring heads the workers’ compensation department at Ethen Ostroff Law, where he takes pride in fighting for injured workers.

Joe is a Philadelphia native and maintains deep roots in the area.  As the grandson of a Philadelphia Firefighter, son of a Philadelphia public school teacher, and veteran of the United State Marine Corps, he was taught to value service, dedication, and hard work.   He applies these values to every case and takes great satisfaction in representing hard-working clients with those same traits.

After obtaining his bachelor’s degree in history from St. Vincent College in Western Pennsylvania, he graduated from Villanova Law School in 2012 and, since then, has litigated hundreds of workers’ compensation hearings and trial depositions on behalf of both employers and injured workers.  During this time, Mr. Ring has written articles and presented Continuing Legal Education courses on developments in Pennsylvania Workers’ Compensation Law.  He is active in local professional organizations, and, in 2022, he served a Co-chairperson of the Philadelphia Bar Associations Workers’ Compensation Section.

Since coming to EOL in 2024, he has dedicated his practice entirely to helping injured workers navigate the system and obtain their rightful benefits.

Joe is licensed to practice in Pennsylvania.

Brandon Zanan heads the personal injury claim department with Ethen Ostroff Law.

Brandon’s education in both law and medicine assist him in expertly representing badly injured victims. Brandon has a Master’s Degree in Forensic Medicine from the Philadelphia College of Osteopathic Medicine, with a concentration in anatomy and pathology. With this knowledge,  Brandon is skilled at analyzing medical records and understanding injuries that are common in personal injury claims. He uses this expertise in conjunction with listening carefully to each client’s needs, in order to fiercely advocate for clients and tell their stories when they would not otherwise have a voice.

Brandon’s background includes a variety of experience and skills in various areas of civil practice. He is the author and editor of numerous books for the George T. Bisel Publishing Company, including “Pennsylvania Damages” and the “Pennsylvania Vehicle Code Annotated,” two texts that are frequently relied on by lawyers and judges across Pennsylvania as authoritative resources on personal injury law.

Brandon is a member of the Pennsylvania and Montgomery Bar Associations. He is also a member of Pennsylvania Association for Justice, and has served as an executive board member of the Montgomery American Inn of Court.

He is admitted to practice in the Commonwealth of Pennsylvania, the United States District Courts for the Eastern District of Pennsylvania and Middle District of Pennsylvania, the State of New Jersey, the United States District Court for the District of New Jersey, and in the Commonwealth of Virginia. Brandon has represented many clients in motor vehicle, premises liability, animal bite, and products liability cases across Pennsylvania and New Jersey and has obtained outstanding results with millions of dollars recovered for his clients.

He has been named a Pennsylvania Rising Star from 2021 onward. The “Super Lawyers-Rising Star®”, list recognizes no more than 2.5 percent of attorneys in each state

Brandon currently lives in Malvern with his wife Rachel and their son Max.

Ethen Ostroff Law, PLLC Terms and Conditions

Effective Date: July 10, 2024

General Information

Welcome to the website of Ethen Ostroff Law, PLLC (“EO”). By accessing or using our website, you agree to be bound by these Terms and Conditions (“Terms”). If you do not agree with these Terms, please do not use our website.

Use

EO hereby grants you a non-exclusive, non-transferable, revocable, limited right and license to access and use the Site solely for your personal use in accordance with these Terms of Use. You shall not, in any way, otherwise copy, reproduce, distribute, transmit, display, perform, reproduce, publish, license, modify, create derivative works from, sell, or exploit the Site.

EO may at any time, for any reason, and without notice or liability: (a) modify, suspend, or terminate operation of or access to the Site and related services, or (b) change, revise, or modify the Site and affiliated services.

Messaging and Automated Calls

When you opt-in, you will receive text messages (SMS/MMS) on your mobile number. These messages may contain information about your case, and the message frequency may vary from user to user. Please note that message and data rates may apply. If you wish to opt out of this service, you can do so anytime by simply texting “STOP” to the phone number. Once you text “STOP” to us, we will send you an SMS to confirm that you have been unsubscribed. If you encounter any issues, you can reply with the keyword “HELP” to get assistance. Please be aware that carriers are not responsible for any delayed or undelivered messages.

By providing your phone number and submitting a form on our website, you consent to receive communications, including automated calls, texts, and pre-recorded messages, from EO and its affiliates. These communications may include updates about your case, promotional offers, and other information. You understand that these calls may be generated using automated technology, and that standard message and data rates may apply.

Your consent to receive automated calls is not a condition of any purchase or service. By checking the consent box on our contact form or by calling our firm, you agree to these Terms and Conditions and provide your written consent to receive these communications. You may opt out of these communications at any time by replying STOP to any text message or by contacting us at [insert contact information].

State-Specific Compliance

EO complies with all federal and state laws regarding automated calls and telemarketing practices. Certain states have additional restrictions on the use of automated dialing systems and pre-recorded messages. The following states have more restrictive regulations:

  • California: Requires prior express written consent for automated calls.
  • Florida: Requires prior express written consent for automated calls and texts.
  • New York: Requires prior express written consent for automated calls.
  • Texas: Requires prior express written consent for automated calls.

If you are a resident of one of these states, EO will obtain your prior express written consent before making any automated calls or sending pre-recorded messages to you.

By submitting a form inquiry or calling our firm, you agree to us contacting you, and your checking the box when submitting your form inquiry serves as written consent.

Information and Legal Disclaimer

The information contained in this website is for informational purposes only, and should not be construed as legal advice. Testimonials and case results contained in this website are for demonstrative purposes only, and do not constitute a guarantee of any particular outcome in a specific case.

By requesting a free consultation with Ethen Ostroff Law, PLLC, you agree to the following:

  • Any information I submit is for review only, and there will be no charge for the initial consultation.
  • I have not entered into an attorney-client relationship with Ethen Ostroff Law, PLLC until such time as a formal written Retainer Agreement is signed by myself and a representative of Ethen Ostroff Law, PLLC. There is no guarantee that Ethen Ostroff Law, PLLC will accept my case.
  • Any information received by Ethen Ostroff Law, PLLC, prior to the execution of a written Retainer Agreement, is not subject to the Attorney-Client Privilege and is not considered confidential.
  • Additional information may be requested in order for Ethen Ostroff Law, PLLC to make a decision on whether or not to accept my case.
  • Because no attorney-client relationship has been established, I will remain personally responsible to meet all necessary deadlines applicable to my claim, until such time as Ethen Ostroff Law, PLLC makes a final decision. I acknowledge that I have not received any representations or legal opinions with respect to any time frames or deadlines that may be applicable to my claim.

No Relationship or Obligation Arises from Use of the Site

The law differs in every jurisdiction, and you should not rely on any opinion except that of an attorney you have retained, who has a professional duty to advise you after being fully informed of all the pertinent facts, and who is licensed in the applicable state, and is familiar with the applicable law. Internet subscribers, mobile application users, and online readers should seek professional counsel about their legal rights and remedies. You should not act or refrain from acting on the basis of any information found on the Site. Any actions or decisions about your legal rights should be based on the particular facts and circumstances of your situation, and appropriate legal advice from an attorney retained directly by you. EO EXPRESSLY DISCLAIMS ALL LIABILITY WITH RESPECT TO ACTIONS TAKEN OR NOT TAKEN BASED UPON ANY INFORMATION OR OTHER CONTENTS OF THIS SITE. Viewing the Site, or communicating with EO by Internet e-mail or through the Site does not constitute or create an attorney-client relationship with anyone. The content and features on the Site do not create, and are not intended to create, an attorney-client relationship, and shall not be construed as legal advice. The content and features of the Site, including means to submit a question or information, do not constitute an offer to represent you or otherwise give rise to an attorney/client relationship.

THE SITE IS PROVIDED “AS IS”. EO MAKES NO WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE SITE AND ONLINE SERVICES AND HEREBY DISCLAIMS ALL WARRANTIES OF ANY KIND OR NATURE, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. WITHOUT LIMITING THE FOREGOING, EO DOES NOT GUARANTEE THAT THE ONLINE SERVICES OR PRODUCTS WILL MEET YOUR REQUIREMENTS, OR WILL BE ERROR-FREE, UNINTERRUPTED, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS, OR THAT ANY DEFECTS WILL BE CORRECTED.

Accounts

To use some features of the Site, you may be required to create an account. In connection therewith, you agree to provide and maintain true, accurate, current, and complete information about yourself. You are responsible for maintaining the confidentiality of the information you hold for your account login, including your password, and for all Submissions made from your account. You agree to notify us immediately of any unauthorized use of your login. EO may suspend access to your account if it suspects illegal or improper use, or for other reasons, such as for account management purposes, at its sole discretion.

Confidentiality is Not Guaranteed

Information sent to Ethen Ostroff Law, PLLC. via Internet e-mail or through the Site is not secure and is done on a non-confidential basis. EO may make reasonable efforts to keep communications private, but because of the nature of Internet communications and the absence of an attorney/client relationship, we cannot promise or guarantee confidentiality.

DISCLAIMER – This Site Does Not Provide Medical Diagnosis or Advice

The content provided on the Site, such as documents, text, graphics, images, videos, news alerts, pharmaceutical drug recalls, prescription medication history, or information on litigation concerning the foregoing topics, or other materials, is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult a physician for diagnosis and treatment of any medical condition or for any questions you may have regarding a health concern. Never disregard professional medical advice, alter a prescription plan in any way, or delay or refrain from seeking medical advice because of something you have read or seen on the Site. Links to other sites are provided for information only. Use of trade names is for identification only and does not constitute endorsement by EO.

Without limiting the generality of the foregoing, the Site may present information about pharmaceutical drug recalls, which is for information purposes only. Such information is not necessarily the most current information on the subject and may or may not be updated based on the last information concerning such recalls. Do not make any decisions regarding medication or medical providers based on information from the Site, including but not limited to information we provide about drug recalls.

EO Is Not Responsible for Content; Limitation on Liability

EO may periodically change, remove, or add the material on the Site without notice. This material may contain technical or typographical errors. EO DOES NOT GUARANTEE ITS ACCURACY, COMPLETENESS OR SUITABILITY. EO assumes no liability or responsibility for any errors or omissions in the contents of the Site. Your use of the Site is at your own risk. Under no circumstances shall EO or any other party involved in the creation, production, or delivery of the Site be liable to you or any other person for any indirect, special, incidental, or consequential damages of any kind arising from your access to, or use of, the Site. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW IN NO EVENT SHALL EO BE LIABLE FOR ANY SPECIAL, INDIRECT, OR CONSEQUENTIAL DAMAGES RELATING TO THIS MATERIAL, FOR ANY USE OF THIS WEBSITE, OR FOR ANY OTHER LINKED WEBSITE.

Third-party Web Sites

The Site contains links to third-party websites for the convenience of our users. EO does not endorse any of these third-party sites and does not imply any association between EO and those sites. EO does not control these third-party websites and cannot represent that their policies and practices will be consistent with these Terms of Use. If you use links to access and use such websites, you do so at your own risk. EO is not responsible for the contents or availability of any linked sites. These links are provided only as a convenience to the recipient. These Terms only apply to the Site and do not apply to any linked sites. We encourage you to read and understand the terms of use of any linked sites that you visit. Links do not imply that we sponsor, endorse, are affiliated with or associated with, or are legally authorized to use any trademark, trade name, service mark, design, logo, symbol, or other copyrighted materials displayed on or accessible through any linked site.

EO Clients

Only individuals who have entered into a mutually signed retainer agreement with EO are EO clients (“EO Clients”).

Legal and Ethical Requirements

EO has tried to comply with all legal and ethical requirements in compiling the Site. We welcome comments about our compliance with the applicable rules and will update the Site as warranted, upon learning of any new or different requirements.

Ethen Ostroff Law reserves the right to refer or sell leads that come through any of Ethen Ostroff Law’s marketing.

Ethen Ostroff Law also may sell leads on certain campaigns generated in association with third party marketing companies.

Governing Laws in Case of Dispute; Jurisdiction

These Terms of Use shall be governed by and construed in accordance with the laws of the State of Pennsylvania, USA, without regard to any choice of law principles. Any and all disputes arising hereunder shall be governed as set forth in the Arbitration section below.

Submissions

You are solely responsible for any information, content, or material you transmit to or through the Site (“Submissions”). You understand that Submissions are considered non-confidential and non-proprietary. Furthermore, you grant EO an unrestricted, irrevocable, perpetual, transferable, sublicensable, worldwide, royalty-free license to use, copy, reproduce, display, publish, publicly perform, transmit, and distribute any Submission, without compensation or accounting to you or anyone else. You represent and warrant that: (a) you have the right to submit the Submission to EO and grant the licenses as described above; (b) EO will not need to obtain licenses from any third party or pay royalties to any third party for its use of the Submission; (c) the Submission does not infringe any third party’s rights, including intellectual property rights and privacy rights; and (d) the Submission complies with these Terms of Use and all applicable laws and regulations.

EO takes no responsibility and assumes no liability for any Submission.

Arbitration

Any and all claims by you arising out of or related to the Site or your use thereof may be resolved only through a binding arbitration proceeding to be conducted under the auspices of the Commercial Arbitration Rules of the American Arbitration Association in Montgomery County, Pennsylvania. Both your agreement to arbitrate all controversies, disputes and claims, and the results and awards rendered through the arbitration, will be final and binding on you and may be specifically enforced by legal proceedings. Arbitration will be the sole means of resolving such controversies, disputes and claims, and you waive your rights to resolve such controversies, disputes and claims by court proceedings or any other means. You agree that judgment may be entered on the award in any court of competent jurisdiction and, therefore, any award rendered shall be binding. The arbitrator may not consolidate more than one person’s claims, and may not otherwise preside over any form of a representative or class proceeding. You understand that by agreeing to arbitration as a mechanism to resolve all controversies, disputes and claims between us, you are waiving certain rights, including the right to bring an action in court, the right to a jury trial, the right to broad discovery, and the right to an appeal. You understand that in the context of arbitration, a case is decided by an arbitrator (one or more), not by a judge or a jury.

International Use

The Site is controlled, operated, and administered by EO from offices within the United States of America and is only intended for use therein. We make no representation regarding use of the Site outside of the United States.

Other Terms

If, for any reason, our Terms of Use, Privacy Policy, or any portion thereof to be unenforceable, such provision shall be enforced to the maximum extent permissible so as to give the intended effect thereof, and the remainder of these Terms of Use and Privacy Policy shall continue in full force and effect. EO’s failure to act with respect to a breach by you or others does not waive our right to act with respect to that breach or subsequent or similar breaches. No consent or waiver by EO hereof will be deemed effective unless in writing. These Terms of Use, together with our Privacy Policy, as each is currently posted, constitute the entire agreement between EO and you with respect to your use of the Site and supersede all previous written or oral agreements relating to the subject matter hereof, that this agreement shall not supersede, restrict, or replace any agreements governing the attorney-client relationship between EO and EO Clients.

EO may, in its sole discretion and without prior notice, block and/or terminate your access to the Site and if we determine that you have violated these Terms of Use or other terms or agreements or that may be associated therewith or if you use the Site in a way that we deem, in our sole discretion, to be an unacceptable use.

Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.